Researchers identified chemical drug combinations that could reverse cellular aging.
FDA drug application costs set to rise to $4.3m from October
Concerns over Jiangsu’s facilities come ahead of the US’s preparations to launch the BIOSECURE Act. Credit: grandbrothers via Shutterstock. The US Food and Drug Administration